Agilent Expands Cross-Vendor CDS Instrument Control

New software extends the company’s compatibility strategy SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) today announced the latest implementation of its mutual compatibility philosophy. Now, joint customers of Agilent Technologies and Thermo Fisher Scientific can choose a chromatography data system from either company—Agilent OpenLab CDS or Thermo Fisher Chromeleon—to control analytical instruments from both organizations. The [...]

BioTek Announces the New Cytation 7 With Upright and Inverted Microscopes, Plus Multi-Mode Detection

WINOOSKI VT, USA — The new Cytation™ 7 Cell Imaging Multi-Mode Reader from BioTek Instruments combines an automated upright microscope, an inverted microscope, and multi-mode microplate detection in a single instrument. This combination of microscopes and multi-mode reading enables applications that would typically require multiple instruments. The inverted microscope supports fluorescence, brightfield, and color brightfield imaging. The [...]

IP Group plc – Portfolio company Oxford Nanopore Technologies announces £109.5m of investment and secondary share sales

IP Group cash realisations in 2019 increased to more than £75m across multiple portfolio holdings IP Group plc (LSE: IPO) ("IP Group" or "the Group"), the developer of intellectual property-based businesses, notes that its portfolio company Oxford Nanopore Technologies Limited (“Oxford Nanopore”) has announced that it has raised £29.3 million of new capital and facilitated [...]

Enhanced Chromatography Data System Software Delivers Improved Efficiency and Compatibility Across the Latest Generation of Analytical Instruments

Thermo Fisher Scientific and Agilent Technologies renew commitment to third-party instrument control, maximizing usability in modern chromatography software solutions San Jose, Calif. – Thermo Fisher Scientific and Agilent Technologies today announced they are continuing their agreement to the industry-wide Instrument Control Exchange Program (ICEP) – fostering compatibility among key vendors’ instrumentation and chromatography data systems [...]

FRITSCH Change of Generations

After almost 40 years as managing director of FRITSCH GmbH, Robert Fritsch was bit farewell on his retirement on 1st January 2020. He looks back on times of modernization, economic growth and success. In 1920 the medium-sized family business was fund in Idar-Oberstein as a technical precious stones dealer by Max and Alfred Fritsch. After [...]

New Resprep Polymeric SPE Offers an Alternative to Silica-Based Sorbents

Restek has expanded its line of Resprep solid phase extraction (SPE) products with the addition of polymeric sorbents, available in both cartridges for high loading capacity and 96-well plates for high throughput and automation. Because Resprep polymeric SPE products feature a silica-free, bonded polymeric material, there are no unwanted secondary silica interactions, even with basic [...]

Enzo Biochem Appoints Rebecca J. Fischer to Board of Directors

NEW YORK -- Enzo Biochem, Inc. (NYSE:ENZ), an integrated diagnostics and life sciences company focusing on delivering and applying advanced technology capabilities to produce affordable, reliable products and services that enable its customers to meet their clinical needs, today announced it has appointed industry healthcare veteran and leader Rebecca J. Fischer to its Board of Directors. Her appointment [...]

Shimadzu and Providence Cancer Institute Partner to Advance Cancer Immunotherapy Research

Shimadzu Corporation (Shimadzu) and the Earle A. Chiles Research Institute, a division of Providence Cancer Institute (Providence) in Portland, Oregon, have entered into a joint research agreement to apply mass spectrometry technology to develop tools for personalized cancer immunotherapeutics. Shimadzu and Providence will develop technologies to reliably identify cancer antigens recognized by an individual’s immune [...]

QIAGEN concludes strategic alternatives review; decides to focus on stand-alone business strategy to drive future value creation

Venlo, The Netherlands – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) (“QIAGEN” or the “Company”) today announced that it has concluded the previously announced review of potential strategic alternatives, and has determined the execution of its current stand-alone business plan represents the best opportunity to drive future value creation. The Supervisory Board and Management Board of QIAGEN, in [...]

Codexis Announces License Agreement with Roche for Enzyme Used in Next Generation Sequencing

REDWOOD CITY, Calif.  -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces a license agreement to provide Roche with Codexis’ EvoT4TM DNA ligase high-performance molecular diagnostic enzyme. This enzyme was developed using Codexis’ proprietary CodeEvolver® protein engineering platform and is expected to be incorporated into Roche’s next generation sequencing (NGS) library preparation kits and other [...]

Access IBO on Knowledge Center